Healthcare and Life Science
Group A Streptococcus: vaccines are now back on the agenda
VacZine Analytics, a specialist publisher in vaccines, has released a new independent commercial forecast for Group A Streptococcus (GAS) vaccines, now that two industry candidates have entered clinical trials. ...
Are we still solving the problem we started with?
By Lily Lin, CEO, Excellence First Enterprise Consultancy (EFEC), and Founder, CognateUK. ...
Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027
· o2h co-discovery to host second edition of the Cambridge x London Life Sciences Showcase, taking place on 13 January 2027 at 111 Minna Gallery, San Francisco · Event is designed to provide a unique platform to spotlight Cambridge and London’s most innovative and pioneer...
Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery
· Nature Biotechnology publication details improved calibration framework for deep learning-based genetic perturbation models· Peer-reviewed study will inform large-scale screen to identify inhibition targets with applications in rejuvenation and age-related disease treatment ...
CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium
Four sessions across twodays focusing on key drug discovery and development application areas of organ-on-a-chip technologies Expert-led presentations and panel discussions featuring leaders across research, regulatory and industry, including Novo Nordisk, Bristol Myers Squibb, and...
Laverock Therapeutics announces in vivo programmes in oncology and genetic medicine
Laverock's programmable gene control platform unlocks in vivo therapeutics with enhanced efficacy and safety ...
Cambridge Forum brings global leaders together to turn AI innovation into impact
Cambridge, UK – September 2026: Cambridge Forum brought together around 200 delegates from the UK and overseas at Cambridge Corn Exchange on 10th and 11th September, creating a multidisciplinary meeting place for some of the most pressing conversations around AI, health and the responsi...
Costello Medical is now Employee-Owned
Costello Medical are proud to share an important milestone in their journey: the transition to employee ownership. ...
Cambridge Mind and Brain Institute launches to address challenges facing our brain health
Cambridge announces a new institute focused on understanding and improving brain health across our lifespan, from early childhood through to old age. ...
Cytotrait appoints Dr Ian Jepson as Non-Executive Director
Accomplished international R&D executive, previously Syngenta, specialising in biotech trait development and genome editing technologiesFollows £3M seed round in 20261 to expand capabilities of the Company’s core MOSS platform and establish trait enhancement programmes in major crop...